Emerging targets in neuroinflammation-driven chronic pain
Current analgesics predominately modulate pain transduction and transmission in neurons
and have limited success in controlling disease progression. Accumulating evidence …
and have limited success in controlling disease progression. Accumulating evidence …
[引用][C] Emerging targets in neuroinflammation-driven chronic pain
RR Ji, ZZ Xu, YJ Gao - Nature Reviews Drug Discovery, 2014 - cir.nii.ac.jp
[PDF][PDF] Emerging targets in neuroinflammation-driven chronic pain
RR Ji, ZZ Xu, YJ Gao - 2014 - researchgate.net
Current analgesics predominately modulate pain transduction and transmission in neurons
and have limited success in controlling disease progression. Accumulating evidence …
and have limited success in controlling disease progression. Accumulating evidence …
[HTML][HTML] Emerging targets in neuroinflammation-driven chronic pain
RR Ji, ZZ Xu, YJ Gao - Nature reviews. Drug discovery, 2014 - ncbi.nlm.nih.gov
Current analgesics predominately modulate pain transduction and transmission in neurons
and have limited success in controlling disease progression. Accumulating evidence …
and have limited success in controlling disease progression. Accumulating evidence …
Emerging targets in neuroinflammation-driven chronic pain.
RR Ji, ZZ Xu, YJ Gao - Nature reviews. Drug Discovery, 2014 - europepmc.org
Current analgesics predominately modulate pain transduction and transmission in neurons
and have limited success in controlling disease progression. Accumulating evidence …
and have limited success in controlling disease progression. Accumulating evidence …
Emerging targets in neuroinflammation-driven chronic pain
RR Ji, ZZ Xu, YJ Gao - Nature reviews. Drug discovery, 2014 - pubmed.ncbi.nlm.nih.gov
Current analgesics predominately modulate pain transduction and transmission in neurons
and have limited success in controlling disease progression. Accumulating evidence …
and have limited success in controlling disease progression. Accumulating evidence …
Emerging targets in neuroinflammation-driven chronic pain.
RR Ji, ZZ Xu, YJ Gao - Nature Reviews Drug Discovery, 2014 - search.ebscohost.com
Current analgesics predominately modulate pain transduction and transmission in neurons
and have limited success in controlling disease progression. Accumulating evidence …
and have limited success in controlling disease progression. Accumulating evidence …
Emerging targets in neuroinflammation-driven chronic pain
RR Ji, ZZ Xu, YJ Gao - Nature Reviews Drug Discovery, 2014 - go.gale.com
Current analgesics predominately modulate pain transduction and transmission in neurons
and have limited success in controlling disease progression. Accumulating evidence …
and have limited success in controlling disease progression. Accumulating evidence …
Emerging targets in neuroinflammation-driven chronic pain.
RR Ji, ZZ Xu, YJ Gao - Nature reviews. Drug Discovery, 2014 - europepmc.org
Current analgesics predominately modulate pain transduction and transmission in neurons
and have limited success in controlling disease progression. Accumulating evidence …
and have limited success in controlling disease progression. Accumulating evidence …